Influenza A+B Ag Rapid Test Strip

Influenza A and Influenza B are major respiratory viruses responsible for seasonal flu outbreaks. Both can cause symptoms such as fever, cough, sore throat, body ache, chills, tiredness, headache, and respiratory discomfort. Influenza A is often associated with larger outbreaks, while Influenza B also contributes significantly to seasonal illness.

• Rapid influenza testing helps healthcare professionals identify possible flu infections quickly.
• Influenza symptoms can overlap with COVID-19, RSV, and other respiratory infections.
• Rapid antigen screening supports infection-control measures and timely patient management.
• Testing for both Influenza A and Influenza B in one strip format helps improve workflow efficiency during seasonal outbreaks.

The Influenza A+B Ag Rapid Test Strip by LARKSOIS Pharma may be used in professional diagnostic and respiratory infection screening environments.

Applications

• Hospitals and clinics
• Diagnostic laboratories
• Emergency departments
• Fever clinics
• Respiratory infection screening programs
• Public health outbreak monitoring
• School and workplace health programs
• Professional point-of-care testing
• International diagnostic distribution

• The Influenza A+B Ag Rapid Test Strip works on lateral flow immunochromatographic assay technology.
• After sample collection, the nasal or nasopharyngeal swab is mixed with extraction buffer.
• The prepared sample is applied to the rapid test strip.
• If Influenza A antigen or Influenza B antigen is present at or above the detection level, it reacts with coated antibodies and forms visible test lines.
• The control line confirms correct sample migration and proper test performance.

The Influenza A+B Ag Rapid Test Strip uses rapid lateral flow immunochromatographic technology for qualitative detection of Influenza A and Influenza B antigens in nasal or nasopharyngeal swab specimens.

Benefits

• Rapid visual result
• Detects both Influenza A and Influenza B antigens
• Uses nasal or nasopharyngeal swab specimens
• Simple strip testing procedure
• No complex instrument required
• Suitable for professional point-of-care testing
• Supports seasonal flu screening
• Professional infectious disease diagnostic application

The Influenza A+B Ag Rapid Test Strip is designed for nasal swab and nasopharyngeal swab specimens. Proper specimen collection is important because sample quality strongly affects test performance.

Guidance

• Use approved nasal or nasopharyngeal swab specimens only
• Collect specimens according to the product insert
• Use clean and suitable swab collection materials
• Avoid contaminated or improperly collected samples
• Mix the swab sample with extraction buffer correctly
• Apply the prepared specimen properly to the strip
• Read results only within the recommended time window
• Handle all respiratory specimens according to laboratory safety procedures

Note

Specimen collection, extraction, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Influenza A+B Ag Rapid Test Strip by LARKSOIS Pharma is designed for qualitative detection of Influenza A and Influenza B antigens in nasal or nasopharyngeal swab specimens. The listed cut-off is 100 TCID/ml, and results should be interpreted with symptoms and clinical findings.

• A positive result means Influenza A antigen or Influenza B antigen has been detected.
• Rapid detection may support timely patient management and infection-control planning.
• A negative result does not completely rule out influenza infection.
• If symptoms strongly suggest flu, molecular testing such as PCR may still be recommended.

Rapid influenza antigen tests provide fast screening results, but molecular methods are generally more accurate. The Influenza A+B Ag Rapid Test Strip should be used as a professional screening aid, not as the only basis for diagnosis or treatment decisions.

Instructions

• For professional in-vitro diagnostic use only
• Use approved respiratory specimens only
• Improper specimen collection may affect results
• False negative or false positive results may occur
• Negative results may require confirmation when symptoms strongly suggest influenza
• PCR testing may be recommended when clinical suspicion remains high
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects both Influenza A and Influenza B antigens
• Uses nasal or nasopharyngeal swab specimens
• Rapid visual strip result
• Simple professional testing workflow
• No complex instrument required
• Useful for seasonal respiratory infection screening
• Suitable for hospitals, clinics, and laboratories
• International-quality product from LARKSOIS Pharma

Note

The Influenza A+B Ag Rapid Test Strip by LARKSOIS Pharma is designed for practical use, rapid screening, and professional healthcare supply requirements.

Steps

• Bring the strip, specimen, and extraction buffer to room temperature
• Collect the nasal or nasopharyngeal swab specimen according to instructions
• Place the swab into the extraction buffer tube
• Mix the sample properly as instructed in the product insert
• Remove the rapid test strip from the sealed pouch
• Apply the prepared specimen according to instructions
• Wait for the recommended reaction time
• Read the test and control lines within the valid time window
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

A positive result means Influenza A antigen or Influenza B antigen has been detected. Results should be interpreted with symptoms, exposure history, and local influenza activity.

Negative

A negative result means Influenza A or B antigen was not detected at the test’s detectable level. If symptoms strongly suggest flu, molecular testing such as PCR may still be recommended.

Invalid

If the control line does not appear, the result is invalid. Testing should be repeated using a fresh rapid test strip.

Instructions

• Store the Influenza A+B Ag Rapid Test Strip according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle respiratory specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the rapid test strip
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and local influenza activity

LARKSOIS Pharma provides globally suitable diagnostic products for healthcare institutions, laboratories, clinics, procurement agencies, and medical distributors. The Influenza A+B Ag Rapid Test Strip is developed for fast, practical, and accessible influenza screening support.

Advantages

• International infectious disease rapid test portfolio
• Reliable respiratory infection screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible Influenza A and B antigen screening solution